MCF Advisors’s Allergan Inc AGN Stock Holding History

MCF Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-75	Closed	-$9K	–	448
2013 Q4	$9K	Hold	75	–	–	﹤0.01%	296
2013 Q3	$9K	Buy	+75	New	+$6.73K	0.01%	291

Other funds holding AGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MCF Advisors's AGN Position: Q1 2014 in Review

MCF Advisors sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 75 shares — an estimated $9K sold.

MCF Advisors first reported a position in AGN in Q3 2013 and held it in 2 quarters. The position peaked at $9K in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

MCF Advisors reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
MCF Advisors sold 75 Allergan Inc shares in Q1 2014, an estimated $9K.
MCF Advisors first reported a position in Allergan Inc in Q3 2013 and held it in 2 quarters.
MCF Advisors's Allergan Inc position peaked at $9K in Q4 2013.
733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on MCF Advisors's 13F filing for Q1 2014, filed 13 May 2014.